These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 6991972

  • 1. Iopamidol, a new non-ionic hydrosoluble contrast medium for neuroradiology.
    Hammer B, Lackner W.
    Neuroradiology; 1980 Apr; 19(3):119-21. PubMed ID: 6991972
    [Abstract] [Full Text] [Related]

  • 2. [Adverse reactions during ascending cervical myelography using iopamidol and metrizamide--a double-blind study].
    Bockenheimer S, Eichenlaub H.
    Rontgenpraxis; 1986 May; 39(5):171-4. PubMed ID: 3523789
    [No Abstract] [Full Text] [Related]

  • 3. Arachnoiditis from myelography with iopamidol, metrizamide, and iocarmate compared in the animal model.
    Haughton VM, Ho KC.
    Invest Radiol; 1980 May; 15(6 Suppl):S267. PubMed ID: 7203934
    [Abstract] [Full Text] [Related]

  • 4. Clinical comparison of metrizamide and iopamidol for myelography.
    Turski PA, Sackett JF, Gentry LR, Strother CM, Matozzi F.
    AJNR Am J Neuroradiol; 1983 May; 4(3):309-11. PubMed ID: 6410729
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Iopamidol vs. metrizamide myelography: clinical comparison of side effects.
    Trevisan C, Malaguti C, Manfredini M, Tampieri D.
    AJNR Am J Neuroradiol; 1983 May; 4(3):306-8. PubMed ID: 6410728
    [Abstract] [Full Text] [Related]

  • 8. A comparative study of two non-ionic contrast media, iopamidol and metrizamide, in translumbar aortography.
    Hacking PM, Soppitt D.
    Clin Radiol; 1983 Jan; 34(1):87-90. PubMed ID: 6337005
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Neuroradiological experiences iopamidol, a new non-ionic hydro-soluble contrast medium. Comparison to metrizamide with special considerations of side effects and pharmacodynamics with regard to clinical use (author's transl)].
    Hammer B.
    Radiologe; 1981 Jun; 21(6):274-81. PubMed ID: 6973775
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Iopamidol and metrizamide for myelography: prospective double-blind clinical trial.
    Witwer G, Cacayorin ED, Bernstein AD, Hubballah MY, Yuan HA, Kieffer SA.
    AJR Am J Roentgenol; 1984 Oct; 143(4):869-73. PubMed ID: 6382981
    [Abstract] [Full Text] [Related]

  • 17. Iopamidol vs metrizamide: a double blind study for cervical myelography.
    Drayer BP, Warner MA, Sudilovsky A, Luther J, Wilkins R, Allen S, Bates M.
    Neuroradiology; 1982 Oct; 24(2):77-84. PubMed ID: 7177374
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The risk of arachnoiditis from experimental nonionic contrast media.
    Haughton VM, Ho KC.
    Radiology; 1980 Aug; 136(2):395-7. PubMed ID: 6773100
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.